Chemicals & Advanced Materials Global On demand · 24-48h

Global Imine Reductase Market Strategic Research Report

Global Imine Reductase Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Imine Reductase Market
$1542025
10%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Imine Reduction Type, Reductive Amination Type, Cyclic Imine Reduction Type

By Application: Pharmaceutical Biocatalysis, Agrochemical Intermediate, Specialty Fine Chemical, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Johnson Matthey, Codexis, Almac Group, Prozomix, SyncoZymes, WuXi STA, Asymchem, Tianjin Bio-Pharmacn Biotechnology, Nanjing Predicte Biotechnology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 95 pages
Market size 2025
$154
Million USD
Forecast CAGR
10%
2025-2032
Forecast 2032
$300.1
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Imine Reductase market size is predicted to grow from US$ 154 million in 2025 to US$ 298 million in 2032; it is expected to grow at a CAGR of 10.0% from 2026 to 2032.

In 2025, global imine reductase(IRED) sales volume was approximately 35 tons, with an average global market price of about USD 4,500/kg. The gross margin of major manufacturers in the industry was approximately 45%–65%.

Imine reductase is a class of oxidoreductase capable of catalyzing the reduction of C=N bonds in imines, iminium ions, or in situ generated imine intermediates to form amine compounds. It is commonly used in the biocatalytic synthesis of chiral amines and amine-containing intermediates. Compared with traditional metal-catalyzed hydrogenation, chemical reduction, or reductive amination processes, imine reductase operates under mild reaction conditions and offers high chemoselectivity and enantioselectivity, helping to reduce metal residues, side reactions, and resolution steps. It is particularly suitable for the green synthesis of pharmaceutical intermediates, chiral amine building blocks, and high-value fine chemicals.

The upstream of imine reductase mainly includes microbial strain resources, enzyme gene sequences, expression vectors, fermentation media, cofactor recycling systems, immobilization carriers, and enzyme formulation excipients. The midstream involves enzyme screening, directed evolution, fermentation expression, purification, immobilization treatment, and process scale-up. Downstream applications are mainly concentrated in pharmaceutical biocatalysis, agrochemical intermediates, and specialty fine chemicals. In pharmaceutical and CDMO applications, imine reductase can be used for the preparation of chiral amines, heterocyclic amines, and API intermediates. In agrochemical and specialty fine chemical applications, it can be used for the synthesis of amine-containing structural fragments, functional amine compounds, and customized high-value intermediates.

Global key Imine Reductase players cover Johnson Matthey, Codexis, Almac Group, Prozomix, SyncoZymes, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Imine Reductase market?

What factors are driving Imine Reductase market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Imine Reductase market opportunities vary by end market size?

How does Imine Reductase break out by Type, by Application?

This report presents a comprehensive overview of the global Imine Reductase market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Imine Reduction Type
  • Reductive Amination Type
  • Cyclic Imine Reduction Type

Segment by Catalytic Selectivity

  • Non-enantioselective Type
  • R-selective Type
  • S-selective Type

Segment by Form

  • Free Enzyme Preparation
  • Immobilized Enzyme Preparation
  • Whole-cell Catalyst

Segment by Application

  • Pharmaceutical Biocatalysis
  • Agrochemical Intermediate
  • Specialty Fine Chemical
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Imine Reductase market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceutical Biocatalysis, Agrochemical Intermediate, Specialty Fine Chemical evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Imine Reductase Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 10%
Regional growth momentum
Market share by segment
Key metrics
Base value
$154
2025
Forecast
$300.1
2032
CAGR
10%
2025–2032
Regions
5
global
Key companies
Johnson MattheyCodexisAlmac GroupProzomixSyncoZymesWuXi STAAsymchemTianjin Bio-Pharmacn Biotechnology
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Imine Reduction TypeReductive Amination TypeCyclic Imine Reduction Type
By Application
Pharmaceutical BiocatalysisAgrochemical IntermediateSpecialty Fine ChemicalOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Imine Reduction Type
  • 3.1.3 Reductive Amination Type
  • 3.1.4 Cyclic Imine Reduction Type
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceutical Biocatalysis
  • 4.1.3 Agrochemical Intermediate
  • 4.1.4 Specialty Fine Chemical
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Johnson Matthey
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Codexis
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Almac Group
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Prozomix
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 SyncoZymes
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 WuXi STA
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Asymchem
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Tianjin Bio-Pharmacn Biotechnology
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Nanjing Predicte Biotechnology
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Imine Reductase market size?
The global Imine Reductase market is estimated at US$ 154 million in 2025 (base year) and is projected to reach US$ 298 million by 2032.
What growth rate is expected for the Imine Reductase market through 2032?
The market is expected to grow at a CAGR of 10.0% from 2026 to 2032, expanding from US$ 154 million in 2025 to US$ 298 million in 2032, roughly 1.9 times its base-year value.
How is Imine Reductase defined?
In 2025, global imine reductase(IRED) sales volume was approximately 35 tons, with an average global market price of about USD 4,500/kg. The gross margin of major manufacturers in the industry was approximately 45%–65%.
What are the main segments of the Imine Reductase market by type?
By type, the market is segmented into Imine Reduction Type, Reductive Amination Type and Cyclic Imine Reduction Type.
Which applications drive demand in the Imine Reductase market?
Key applications covered include Pharmaceutical Biocatalysis, Agrochemical Intermediate, Specialty Fine Chemical and Other.
Who are the key players in the Imine Reductase market?
Key players profiled include Johnson Matthey, Codexis, Almac Group, Prozomix, SyncoZymes, WuXi STA, Asymchem and Tianjin Bio-Pharmacn Biotechnology, among 9 companies covered in total.
Which regions and countries are covered for Imine Reductase?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Imine Reductase market?
What factors are driving Imine Reductase market growth, globally and by region?
Who should buy the Imine Reductase market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical Biocatalysis, Agrochemical Intermediate and Specialty Fine Chemical, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Imine Reductase market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.